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Résumé en
anglais
Ethambutol (EMB), widely used in the treatment of tuberculosis, has been
reported to cause Leber’s hereditary optic neuropathy in patients carrying
mitochondrial DNA mutations. We study the effect of EMB on mitochondrial
metabolism in fibroblasts from controls and from a man carrying an OPA1
mutation, in whom the drug induced the development of autosomal dominant optic
atrophy (ADOA). EMB produced a mitochondrial coupling defect together with a
25% reduction in complex IV activity. EMB induced the formation of vacuoles
associated with decreased mitochondrial membrane potential and increased
fragmentation of the mitochondrial network. Mitochondrial genetic variations may
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